المؤلفون: Theeler BJ, van der Knaap MS

المصدر: Neurology; 8/11/2009, Vol. 73 Issue 6, p488-489, 2p

المؤلفون: Rogers JL; Neuro-Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, 9030 Old Georgetown Rd, Bethesda, MD, 20892, USA., Wall T; Neuro-Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, 9030 Old Georgetown Rd, Bethesda, MD, 20892, USA., Acquaye-Mallory AA; Neuro-Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, 9030 Old Georgetown Rd, Bethesda, MD, 20892, USA., Boris L; Neuro-Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, 9030 Old Georgetown Rd, Bethesda, MD, 20892, USA., Kim Y; Neuro-Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, 9030 Old Georgetown Rd, Bethesda, MD, 20892, USA.; Wayne State University School of Medicine, 540 E Canfield St, Detroit, MI, 48201, USA., Aldape K; Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, 10 Center Dr, Bethesda, MD, 20892, USA., Quezado MM; Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, 10 Center Dr, Bethesda, MD, 20892, USA., Butman JA; Radiology and Imaging Sciences, Clinical Center, National Institutes of Health, 10 Center Dr, Bethesda, MD, 20892, USA., Smirniotopoulos JG; Neuro-Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, 9030 Old Georgetown Rd, Bethesda, MD, 20892, USA., Chaudhry H; Radiation Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, 10 Center Dr, Bethesda, MD, 20892, USA., Tsien CI; Neuro-Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, 9030 Old Georgetown Rd, Bethesda, MD, 20892, USA.; Proton Therapy Center, Sibley Memorial Hospital, Johns Hopkins Medicine, 5255 Loughboro Rd NW, Washington, DC, 20016, USA., Chittiboina P; Surgical Neurology Branch,, National Institute of Neurological Disorders and Stroke, National Institutes of Health, 10 Center Dr, Bethesda, MD, 20892, USA., Zaghloul K; Surgical Neurology Branch,, National Institute of Neurological Disorders and Stroke, National Institutes of Health, 10 Center Dr, Bethesda, MD, 20892, USA., Aboud O; Department of Neurology and Neurological Surgery, UC Davis Comprehensive Cancer Center, 4860 Y Street, Sacramento, CA, 95817, USA., Avgeropoulos NG; Brain and Spine Tumor Program, Orlando Health Cancer Institute, 1400 S. Orange Ave, Orlando, FL, 32806, USA.; Global Medical Affairs, Novocure GmbH, D4 Pk. 6, 6039, Root, Switzerland., Burton EC; Neuro-Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, 9030 Old Georgetown Rd, Bethesda, MD, 20892, USA., Cachia DM; Department of Hematology/Oncology, University of Massachusetts, 55 Lake Ave, Worcester, MA, 01655, USA., Dixit KS; Lou and Jean Malnati Brain Tumor Institute, Northwestern University Feinberg School of Medicine, 675 N St Clair St, Chicago, IL, 60611, USA., Drappatz J; Department of Neurology, University of Pittsburgh Medical Center, 5115 Centre Ave, Pittsburgh, PA, 15232, USA., Dunbar EM; Piedmont Brain Tumor Center, Piedmont Atlanta Hospital, Atlanta, GA, 2001 Peachtree St30309, USA., Forsyth P; Department of Neuro-Oncology, Moffitt Cancer Center, 12902 USF Magnolia Drive, Tampa, FL, 33612, USA., Komlodi-Pasztor E; Neuro-Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, 9030 Old Georgetown Rd, Bethesda, MD, 20892, USA.; Department of Neurology, MedStar Georgetown University Hospital, 3800 Reservoir Road Washington, Washington DC, 20007, USA., Mandel J; Department of Neurology, Baylor College of Medicine, 7200 Cambridge St, Houston, TX, 77030, USA., Ozer BH; Neuro-Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, 9030 Old Georgetown Rd, Bethesda, MD, 20892, USA., Lee EQ; Center for Neuro-Oncology, Dana Farber Cancer Institute, 450 Brookline Ave, Boston, MA, 02215, USA., Ranjan S; Department of Neurology, Cleveland Clinic Florida, Weston Hospital, 2950 Cleveland Clinic Boulevard, Weston, FL, 33331, US., Lukas RV; Lou and Jean Malnati Brain Tumor Institute, Northwestern University Feinberg School of Medicine, 675 N St Clair St, Chicago, IL, 60611, USA., Raygada M; Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, 1 Center Dr, Bethesda, MD, 20892, USA., Salacz ME; Department of Hematology and Medical Oncology, MD Anderson Cancer Center at Cooper, Cooper University Health Care, Two Cooper Plaza, Camden, NJ, 08103, USA., Smith-Cohn MA; Neuro-Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, 9030 Old Georgetown Rd, Bethesda, MD, 20892, USA.; Benefis Sletten Cancer Institute, 1117 29Th St. S, Great Falls, MT, 59405, USA., Snyder J; Hermelin Brain Tumor Center, Henry Ford Cancer Institute, 2800 W Grand Blvd, Detroit, MI, 48202, USA., Soldatos A; National Institute of Neurological Disorders and Stroke,, National Institutes of Health, 10 Center Dr, Bethesda, MD, 20892, USA., Theeler BJ; School of Medicine, Uniformed Services University, 4301 Jones Bridge Rd, Bethesda, MD, 20814, USA., Widemann BC; Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, 10 Center Dr, Bethesda, MD, 20892, USA., Camphausen KA; Radiation Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, 10 Center Dr, Bethesda, MD, 20892, USA., Heiss JD; Surgical Neurology Branch,, National Institute of Neurological Disorders and Stroke, National Institutes of Health, 10 Center Dr, Bethesda, MD, 20892, USA., Armstrong TS; Neuro-Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, 9030 Old Georgetown Rd, Bethesda, MD, 20892, USA., Gilbert MR; Neuro-Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, 9030 Old Georgetown Rd, Bethesda, MD, 20892, USA., Penas-Prado M; Neuro-Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, 9030 Old Georgetown Rd, Bethesda, MD, 20892, USA. marta.penas-prado@nih.gov.

المصدر: Journal of neuro-oncology [J Neurooncol] 2024 Apr; Vol. 167 (2), pp. 349-359. Date of Electronic Publication: 2024 Mar 01.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Springer Country of Publication: United States NLM ID: 8309335 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-7373 (Electronic) Linking ISSN: 0167594X NLM ISO Abbreviation: J Neurooncol Subsets: MEDLINE

مواضيع طبية MeSH: Pandemics* , Central Nervous System Neoplasms*/diagnosis , Central Nervous System Neoplasms*/therapy, Humans ; Retrospective Studies ; Patient Care Team ; Referral and Consultation

المؤلفون: Briceno N; Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA., Vera E; Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA., Komlodi-Pasztor E; Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA., Abdullaev Z; Laboratory of Pathology, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA., Choi A; Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA., Grajkowska E; Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA., Kunst T; Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA., Levine J; Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA., Lindsley M; Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA., Fernandez K; Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA., Reyes J; Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA., Boris L; Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Inc., Frederick, Maryland, USA., Burton E; Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA., Panzer M; Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA., Polskin L; Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA., Penas-Prado M; Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA., Pillai T; Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA., Theeler BJ; Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA., Wu J; Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA., Wall K; Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA., Papanicolau-Sengos A; Laboratory of Pathology, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA., Quezado M; Laboratory of Pathology, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA., Smirniotopoulos J; George Washington University School of Medicine and Health Sciences, Washington, District of Columbia, USA.; MedPix, National Library of Medicine, Bethesda, Maryland, USA., Aldape K; Laboratory of Pathology, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA., Armstrong TS; Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA., Gilbert MR; Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.

المصدر: Neuro-oncology advances [Neurooncol Adv] 2024 Feb 08; Vol. 6 (1), pp. vdae019. Date of Electronic Publication: 2024 Feb 08 (Print Publication: 2024).

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Oxford University Press Country of Publication: England NLM ID: 101755003 Publication Model: eCollection Cited Medium: Internet ISSN: 2632-2498 (Electronic) Linking ISSN: 26322498 NLM ISO Abbreviation: Neurooncol Adv Subsets: PubMed not MEDLINE

المؤلفون: Yu N; University of California, Davis School of Medicine, Sacramento, CA, USA., Raslan OA; Department of Radiology, Division of Neuroradiology, University of California Davis, Sacramento, CA 95817, USA., Lee HS; Department of Pathology, University of California Davis, Sacramento, CA 95817, USA., Theeler BJ; Uniformed Services University of the Health Sciences, Bethesda, MD 20814, USA., Raafat TA; Department of Radiology, National Cancer Institute, Cairo University, Cairo, Egypt., Fragoso R; Department of Radiation Oncology, University of California, Davis, Sacramento, CA 95817, USA., Shahlaie K; Department of Neurological Surgery, University of California, Davis, Sacramento, CA 95817, USA., Aboud O; Department of Neurological Surgery, University of California, Davis, Sacramento, CA 95817, USA.; Department of Neurology, University of California, Davis, Sacramento, CA 95817, USA.; Comprehensive Cancer Center, University of California Davis, Sacramento, CA 95817, USA.

المصدر: CNS oncology [CNS Oncol] 2024 Jan 01; Vol. 13 (1), pp. CNS106. Date of Electronic Publication: 2024 Feb 13.

نوع المنشور: Review; Case Reports; Journal Article; Research Support, N.I.H., Extramural

بيانات الدورية: Publisher: Future Medicine Country of Publication: England NLM ID: 101594668 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2045-0915 (Electronic) Linking ISSN: 20450907 NLM ISO Abbreviation: CNS Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Craniopharyngioma*/drug therapy , Pituitary Neoplasms*/diagnostic imaging , Pituitary Neoplasms*/drug therapy , Pituitary Neoplasms*/genetics , Azetidines* , Piperidines*, Male ; Humans ; Middle Aged ; Vemurafenib/therapeutic use ; Proto-Oncogene Proteins B-raf/genetics ; Mutation/genetics

المؤلفون: Leeper HE; From the Neuro-Oncology Branch (H.E.L., E.V., A. Christ, A.A., N.B., A. Choi, E.G., V.J., M.L., J.R., K.N.R., J.L.R., M.T., E.B., M.P.-P., V.P., L.P., B.J.T., J.W., M.R.G., T.S.A.), and Office of Information Technology (J.L.), Center for Cancer Research, National Cancer Institute, NIH, Bethesda; Leidos Biomedical Research (L.B., M.P.), Frederick National Laboratory for Cancer Research Sponsored by the National Cancer Institute, MD; Concentric Methods, LLC (N.L.), Manassas, VA; and Department of Neurology (B.J.T.), Uniformed Services University of the Health Sciences, Bethesda, MD. hleeper@uchicagomedicine.org., Vera E; From the Neuro-Oncology Branch (H.E.L., E.V., A. Christ, A.A., N.B., A. Choi, E.G., V.J., M.L., J.R., K.N.R., J.L.R., M.T., E.B., M.P.-P., V.P., L.P., B.J.T., J.W., M.R.G., T.S.A.), and Office of Information Technology (J.L.), Center for Cancer Research, National Cancer Institute, NIH, Bethesda; Leidos Biomedical Research (L.B., M.P.), Frederick National Laboratory for Cancer Research Sponsored by the National Cancer Institute, MD; Concentric Methods, LLC (N.L.), Manassas, VA; and Department of Neurology (B.J.T.), Uniformed Services University of the Health Sciences, Bethesda, MD., Christ A; From the Neuro-Oncology Branch (H.E.L., E.V., A. Christ, A.A., N.B., A. Choi, E.G., V.J., M.L., J.R., K.N.R., J.L.R., M.T., E.B., M.P.-P., V.P., L.P., B.J.T., J.W., M.R.G., T.S.A.), and Office of Information Technology (J.L.), Center for Cancer Research, National Cancer Institute, NIH, Bethesda; Leidos Biomedical Research (L.B., M.P.), Frederick National Laboratory for Cancer Research Sponsored by the National Cancer Institute, MD; Concentric Methods, LLC (N.L.), Manassas, VA; and Department of Neurology (B.J.T.), Uniformed Services University of the Health Sciences, Bethesda, MD., Acquaye A; From the Neuro-Oncology Branch (H.E.L., E.V., A. Christ, A.A., N.B., A. Choi, E.G., V.J., M.L., J.R., K.N.R., J.L.R., M.T., E.B., M.P.-P., V.P., L.P., B.J.T., J.W., M.R.G., T.S.A.), and Office of Information Technology (J.L.), Center for Cancer Research, National Cancer Institute, NIH, Bethesda; Leidos Biomedical Research (L.B., M.P.), Frederick National Laboratory for Cancer Research Sponsored by the National Cancer Institute, MD; Concentric Methods, LLC (N.L.), Manassas, VA; and Department of Neurology (B.J.T.), Uniformed Services University of the Health Sciences, Bethesda, MD., Briceno N; From the Neuro-Oncology Branch (H.E.L., E.V., A. Christ, A.A., N.B., A. Choi, E.G., V.J., M.L., J.R., K.N.R., J.L.R., M.T., E.B., M.P.-P., V.P., L.P., B.J.T., J.W., M.R.G., T.S.A.), and Office of Information Technology (J.L.), Center for Cancer Research, National Cancer Institute, NIH, Bethesda; Leidos Biomedical Research (L.B., M.P.), Frederick National Laboratory for Cancer Research Sponsored by the National Cancer Institute, MD; Concentric Methods, LLC (N.L.), Manassas, VA; and Department of Neurology (B.J.T.), Uniformed Services University of the Health Sciences, Bethesda, MD., Choi A; From the Neuro-Oncology Branch (H.E.L., E.V., A. Christ, A.A., N.B., A. Choi, E.G., V.J., M.L., J.R., K.N.R., J.L.R., M.T., E.B., M.P.-P., V.P., L.P., B.J.T., J.W., M.R.G., T.S.A.), and Office of Information Technology (J.L.), Center for Cancer Research, National Cancer Institute, NIH, Bethesda; Leidos Biomedical Research (L.B., M.P.), Frederick National Laboratory for Cancer Research Sponsored by the National Cancer Institute, MD; Concentric Methods, LLC (N.L.), Manassas, VA; and Department of Neurology (B.J.T.), Uniformed Services University of the Health Sciences, Bethesda, MD., Grajkowska E; From the Neuro-Oncology Branch (H.E.L., E.V., A. Christ, A.A., N.B., A. Choi, E.G., V.J., M.L., J.R., K.N.R., J.L.R., M.T., E.B., M.P.-P., V.P., L.P., B.J.T., J.W., M.R.G., T.S.A.), and Office of Information Technology (J.L.), Center for Cancer Research, National Cancer Institute, NIH, Bethesda; Leidos Biomedical Research (L.B., M.P.), Frederick National Laboratory for Cancer Research Sponsored by the National Cancer Institute, MD; Concentric Methods, LLC (N.L.), Manassas, VA; and Department of Neurology (B.J.T.), Uniformed Services University of the Health Sciences, Bethesda, MD., Jammula V; From the Neuro-Oncology Branch (H.E.L., E.V., A. Christ, A.A., N.B., A. Choi, E.G., V.J., M.L., J.R., K.N.R., J.L.R., M.T., E.B., M.P.-P., V.P., L.P., B.J.T., J.W., M.R.G., T.S.A.), and Office of Information Technology (J.L.), Center for Cancer Research, National Cancer Institute, NIH, Bethesda; Leidos Biomedical Research (L.B., M.P.), Frederick National Laboratory for Cancer Research Sponsored by the National Cancer Institute, MD; Concentric Methods, LLC (N.L.), Manassas, VA; and Department of Neurology (B.J.T.), Uniformed Services University of the Health Sciences, Bethesda, MD., Levine J; From the Neuro-Oncology Branch (H.E.L., E.V., A. Christ, A.A., N.B., A. Choi, E.G., V.J., M.L., J.R., K.N.R., J.L.R., M.T., E.B., M.P.-P., V.P., L.P., B.J.T., J.W., M.R.G., T.S.A.), and Office of Information Technology (J.L.), Center for Cancer Research, National Cancer Institute, NIH, Bethesda; Leidos Biomedical Research (L.B., M.P.), Frederick National Laboratory for Cancer Research Sponsored by the National Cancer Institute, MD; Concentric Methods, LLC (N.L.), Manassas, VA; and Department of Neurology (B.J.T.), Uniformed Services University of the Health Sciences, Bethesda, MD., Lindsley M; From the Neuro-Oncology Branch (H.E.L., E.V., A. Christ, A.A., N.B., A. Choi, E.G., V.J., M.L., J.R., K.N.R., J.L.R., M.T., E.B., M.P.-P., V.P., L.P., B.J.T., J.W., M.R.G., T.S.A.), and Office of Information Technology (J.L.), Center for Cancer Research, National Cancer Institute, NIH, Bethesda; Leidos Biomedical Research (L.B., M.P.), Frederick National Laboratory for Cancer Research Sponsored by the National Cancer Institute, MD; Concentric Methods, LLC (N.L.), Manassas, VA; and Department of Neurology (B.J.T.), Uniformed Services University of the Health Sciences, Bethesda, MD., Reyes J; From the Neuro-Oncology Branch (H.E.L., E.V., A. Christ, A.A., N.B., A. Choi, E.G., V.J., M.L., J.R., K.N.R., J.L.R., M.T., E.B., M.P.-P., V.P., L.P., B.J.T., J.W., M.R.G., T.S.A.), and Office of Information Technology (J.L.), Center for Cancer Research, National Cancer Institute, NIH, Bethesda; Leidos Biomedical Research (L.B., M.P.), Frederick National Laboratory for Cancer Research Sponsored by the National Cancer Institute, MD; Concentric Methods, LLC (N.L.), Manassas, VA; and Department of Neurology (B.J.T.), Uniformed Services University of the Health Sciences, Bethesda, MD., Roche KN; From the Neuro-Oncology Branch (H.E.L., E.V., A. Christ, A.A., N.B., A. Choi, E.G., V.J., M.L., J.R., K.N.R., J.L.R., M.T., E.B., M.P.-P., V.P., L.P., B.J.T., J.W., M.R.G., T.S.A.), and Office of Information Technology (J.L.), Center for Cancer Research, National Cancer Institute, NIH, Bethesda; Leidos Biomedical Research (L.B., M.P.), Frederick National Laboratory for Cancer Research Sponsored by the National Cancer Institute, MD; Concentric Methods, LLC (N.L.), Manassas, VA; and Department of Neurology (B.J.T.), Uniformed Services University of the Health Sciences, Bethesda, MD., Rogers JL; From the Neuro-Oncology Branch (H.E.L., E.V., A. Christ, A.A., N.B., A. Choi, E.G., V.J., M.L., J.R., K.N.R., J.L.R., M.T., E.B., M.P.-P., V.P., L.P., B.J.T., J.W., M.R.G., T.S.A.), and Office of Information Technology (J.L.), Center for Cancer Research, National Cancer Institute, NIH, Bethesda; Leidos Biomedical Research (L.B., M.P.), Frederick National Laboratory for Cancer Research Sponsored by the National Cancer Institute, MD; Concentric Methods, LLC (N.L.), Manassas, VA; and Department of Neurology (B.J.T.), Uniformed Services University of the Health Sciences, Bethesda, MD., Timmer M; From the Neuro-Oncology Branch (H.E.L., E.V., A. Christ, A.A., N.B., A. Choi, E.G., V.J., M.L., J.R., K.N.R., J.L.R., M.T., E.B., M.P.-P., V.P., L.P., B.J.T., J.W., M.R.G., T.S.A.), and Office of Information Technology (J.L.), Center for Cancer Research, National Cancer Institute, NIH, Bethesda; Leidos Biomedical Research (L.B., M.P.), Frederick National Laboratory for Cancer Research Sponsored by the National Cancer Institute, MD; Concentric Methods, LLC (N.L.), Manassas, VA; and Department of Neurology (B.J.T.), Uniformed Services University of the Health Sciences, Bethesda, MD., Boris L; From the Neuro-Oncology Branch (H.E.L., E.V., A. Christ, A.A., N.B., A. Choi, E.G., V.J., M.L., J.R., K.N.R., J.L.R., M.T., E.B., M.P.-P., V.P., L.P., B.J.T., J.W., M.R.G., T.S.A.), and Office of Information Technology (J.L.), Center for Cancer Research, National Cancer Institute, NIH, Bethesda; Leidos Biomedical Research (L.B., M.P.), Frederick National Laboratory for Cancer Research Sponsored by the National Cancer Institute, MD; Concentric Methods, LLC (N.L.), Manassas, VA; and Department of Neurology (B.J.T.), Uniformed Services University of the Health Sciences, Bethesda, MD., Burton E; From the Neuro-Oncology Branch (H.E.L., E.V., A. Christ, A.A., N.B., A. Choi, E.G., V.J., M.L., J.R., K.N.R., J.L.R., M.T., E.B., M.P.-P., V.P., L.P., B.J.T., J.W., M.R.G., T.S.A.), and Office of Information Technology (J.L.), Center for Cancer Research, National Cancer Institute, NIH, Bethesda; Leidos Biomedical Research (L.B., M.P.), Frederick National Laboratory for Cancer Research Sponsored by the National Cancer Institute, MD; Concentric Methods, LLC (N.L.), Manassas, VA; and Department of Neurology (B.J.T.), Uniformed Services University of the Health Sciences, Bethesda, MD., Lollo N; From the Neuro-Oncology Branch (H.E.L., E.V., A. Christ, A.A., N.B., A. Choi, E.G., V.J., M.L., J.R., K.N.R., J.L.R., M.T., E.B., M.P.-P., V.P., L.P., B.J.T., J.W., M.R.G., T.S.A.), and Office of Information Technology (J.L.), Center for Cancer Research, National Cancer Institute, NIH, Bethesda; Leidos Biomedical Research (L.B., M.P.), Frederick National Laboratory for Cancer Research Sponsored by the National Cancer Institute, MD; Concentric Methods, LLC (N.L.), Manassas, VA; and Department of Neurology (B.J.T.), Uniformed Services University of the Health Sciences, Bethesda, MD., Panzer M; From the Neuro-Oncology Branch (H.E.L., E.V., A. Christ, A.A., N.B., A. Choi, E.G., V.J., M.L., J.R., K.N.R., J.L.R., M.T., E.B., M.P.-P., V.P., L.P., B.J.T., J.W., M.R.G., T.S.A.), and Office of Information Technology (J.L.), Center for Cancer Research, National Cancer Institute, NIH, Bethesda; Leidos Biomedical Research (L.B., M.P.), Frederick National Laboratory for Cancer Research Sponsored by the National Cancer Institute, MD; Concentric Methods, LLC (N.L.), Manassas, VA; and Department of Neurology (B.J.T.), Uniformed Services University of the Health Sciences, Bethesda, MD., Penas-Prado M; From the Neuro-Oncology Branch (H.E.L., E.V., A. Christ, A.A., N.B., A. Choi, E.G., V.J., M.L., J.R., K.N.R., J.L.R., M.T., E.B., M.P.-P., V.P., L.P., B.J.T., J.W., M.R.G., T.S.A.), and Office of Information Technology (J.L.), Center for Cancer Research, National Cancer Institute, NIH, Bethesda; Leidos Biomedical Research (L.B., M.P.), Frederick National Laboratory for Cancer Research Sponsored by the National Cancer Institute, MD; Concentric Methods, LLC (N.L.), Manassas, VA; and Department of Neurology (B.J.T.), Uniformed Services University of the Health Sciences, Bethesda, MD., Pillai V; From the Neuro-Oncology Branch (H.E.L., E.V., A. Christ, A.A., N.B., A. Choi, E.G., V.J., M.L., J.R., K.N.R., J.L.R., M.T., E.B., M.P.-P., V.P., L.P., B.J.T., J.W., M.R.G., T.S.A.), and Office of Information Technology (J.L.), Center for Cancer Research, National Cancer Institute, NIH, Bethesda; Leidos Biomedical Research (L.B., M.P.), Frederick National Laboratory for Cancer Research Sponsored by the National Cancer Institute, MD; Concentric Methods, LLC (N.L.), Manassas, VA; and Department of Neurology (B.J.T.), Uniformed Services University of the Health Sciences, Bethesda, MD., Polskin L; From the Neuro-Oncology Branch (H.E.L., E.V., A. Christ, A.A., N.B., A. Choi, E.G., V.J., M.L., J.R., K.N.R., J.L.R., M.T., E.B., M.P.-P., V.P., L.P., B.J.T., J.W., M.R.G., T.S.A.), and Office of Information Technology (J.L.), Center for Cancer Research, National Cancer Institute, NIH, Bethesda; Leidos Biomedical Research (L.B., M.P.), Frederick National Laboratory for Cancer Research Sponsored by the National Cancer Institute, MD; Concentric Methods, LLC (N.L.), Manassas, VA; and Department of Neurology (B.J.T.), Uniformed Services University of the Health Sciences, Bethesda, MD., Theeler BJ; From the Neuro-Oncology Branch (H.E.L., E.V., A. Christ, A.A., N.B., A. Choi, E.G., V.J., M.L., J.R., K.N.R., J.L.R., M.T., E.B., M.P.-P., V.P., L.P., B.J.T., J.W., M.R.G., T.S.A.), and Office of Information Technology (J.L.), Center for Cancer Research, National Cancer Institute, NIH, Bethesda; Leidos Biomedical Research (L.B., M.P.), Frederick National Laboratory for Cancer Research Sponsored by the National Cancer Institute, MD; Concentric Methods, LLC (N.L.), Manassas, VA; and Department of Neurology (B.J.T.), Uniformed Services University of the Health Sciences, Bethesda, MD., Wu J; From the Neuro-Oncology Branch (H.E.L., E.V., A. Christ, A.A., N.B., A. Choi, E.G., V.J., M.L., J.R., K.N.R., J.L.R., M.T., E.B., M.P.-P., V.P., L.P., B.J.T., J.W., M.R.G., T.S.A.), and Office of Information Technology (J.L.), Center for Cancer Research, National Cancer Institute, NIH, Bethesda; Leidos Biomedical Research (L.B., M.P.), Frederick National Laboratory for Cancer Research Sponsored by the National Cancer Institute, MD; Concentric Methods, LLC (N.L.), Manassas, VA; and Department of Neurology (B.J.T.), Uniformed Services University of the Health Sciences, Bethesda, MD., Gilbert MR; From the Neuro-Oncology Branch (H.E.L., E.V., A. Christ, A.A., N.B., A. Choi, E.G., V.J., M.L., J.R., K.N.R., J.L.R., M.T., E.B., M.P.-P., V.P., L.P., B.J.T., J.W., M.R.G., T.S.A.), and Office of Information Technology (J.L.), Center for Cancer Research, National Cancer Institute, NIH, Bethesda; Leidos Biomedical Research (L.B., M.P.), Frederick National Laboratory for Cancer Research Sponsored by the National Cancer Institute, MD; Concentric Methods, LLC (N.L.), Manassas, VA; and Department of Neurology (B.J.T.), Uniformed Services University of the Health Sciences, Bethesda, MD., Armstrong TS; From the Neuro-Oncology Branch (H.E.L., E.V., A. Christ, A.A., N.B., A. Choi, E.G., V.J., M.L., J.R., K.N.R., J.L.R., M.T., E.B., M.P.-P., V.P., L.P., B.J.T., J.W., M.R.G., T.S.A.), and Office of Information Technology (J.L.), Center for Cancer Research, National Cancer Institute, NIH, Bethesda; Leidos Biomedical Research (L.B., M.P.), Frederick National Laboratory for Cancer Research Sponsored by the National Cancer Institute, MD; Concentric Methods, LLC (N.L.), Manassas, VA; and Department of Neurology (B.J.T.), Uniformed Services University of the Health Sciences, Bethesda, MD.

المصدر: Neurology [Neurology] 2023 Apr 18; Vol. 100 (16), pp. e1723-e1736. Date of Electronic Publication: 2023 Feb 08.

نوع المنشور: Observational Study; Journal Article; Research Support, N.I.H., Intramural

بيانات الدورية: Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 0401060 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1526-632X (Electronic) Linking ISSN: 00283878 NLM ISO Abbreviation: Neurology Subsets: MEDLINE

مواضيع طبية MeSH: Quality of Life* , Brain Neoplasms*, Humans ; Male ; Female ; Adolescent ; Young Adult ; Adult ; Middle Aged ; Aged ; Employment ; Anxiety ; Anxiety Disorders

المؤلفون: King AL; Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, USA. amanda.king2@nih.gov.; Office of Patient-Centered Outcomes Research, National Cancer Institute, National Institutes of Health, 9030 Old Georgetown Road, Bethesda, MD, 20892, USA. amanda.king2@nih.gov., Roche KN; Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, USA., Leeper HE; Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, USA., Vera E; Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, USA.; Office of Patient-Centered Outcomes Research, National Cancer Institute, National Institutes of Health, 9030 Old Georgetown Road, Bethesda, MD, 20892, USA., Mendoza T; Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, USA.; Office of Patient-Centered Outcomes Research, National Cancer Institute, National Institutes of Health, 9030 Old Georgetown Road, Bethesda, MD, 20892, USA., Mentges K; Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Inc., Frederick, USA., Acquaye-Mallory AA; Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, USA., Adegbesan KA; Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, USA., Boris L; Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Inc., Frederick, USA., Burton E; Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, USA., Choi A; Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, USA., Grajkowska E; Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Inc., Frederick, USA., Kunst T; Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, USA., Levine J; Center for Cancer Research Office of Information Technology, National Cancer Institute, National Institutes of Health, Bethesda, USA., Lollo N; Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, USA., Miller H; Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, USA., Panzer M; Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Inc., Frederick, USA., Penas-Prado M; Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, USA., Pillai V; Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Inc., Frederick, USA., Polskin L; Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Inc., Frederick, USA., Reyes J; Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, USA., Sahebjam S; Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, USA., Stockdill ML; Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, USA., Theeler BJ; Uniformed Services University of the Health Sciences, Bethesda, USA., Wu J; Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, USA., Gilbert MR; Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, USA., Armstrong TS; Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, USA.

المصدر: Journal of neuro-oncology [J Neurooncol] 2023 Mar; Vol. 162 (1), pp. 137-145. Date of Electronic Publication: 2023 Mar 08.

نوع المنشور: Clinical Trial, Phase II; Journal Article

بيانات الدورية: Publisher: Springer Country of Publication: United States NLM ID: 8309335 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-7373 (Electronic) Linking ISSN: 0167594X NLM ISO Abbreviation: J Neurooncol Subsets: MEDLINE

مواضيع طبية MeSH: Virtual Reality Exposure Therapy* , Brain Neoplasms*/complications , Brain Neoplasms*/therapy, Adult ; Humans ; Male ; Female ; Feasibility Studies ; Anxiety/etiology ; Anxiety/therapy

المؤلفون: Sass D; Neuro-Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA. Electronic address: delia.sass@nih.gov., Vera E; Neuro-Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Choi A; Neuro-Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Acquaye A; Neuro-Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Briceno N; Neuro-Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Christ A; Neuro-Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Grajkowska E; Neuro-Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Jammula V; Neuro-Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Levine J; Office of Information Technology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Lindsley M; Neuro-Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Reyes J; Neuro-Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Roche K; Neuro-Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Rogers JL; Neuro-Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Timmer M; Neuro-Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Boris L; Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Inc, Frederick, MD, USA., Burton E; Neuro-Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Lollo N; Neuro-Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Panzer M; Neuro-Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Penas-Prado M; Neuro-Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Pillai V; Neuro-Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Polskin L; Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Inc, Frederick, MD, USA., Theeler BJ; Department of Neurology, Uniformed Services University of the Health Sciences, Bethesda, MD, USA., Wu J; Neuro-Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Gilbert MR; Neuro-Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Armstrong TS; Neuro-Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Leeper H; Neuro-Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.

المصدر: Journal of geriatric oncology [J Geriatr Oncol] 2022 Nov; Vol. 13 (8), pp. 1194-1202. Date of Electronic Publication: 2022 Aug 28.

نوع المنشور: Journal Article; Research Support, N.I.H., Intramural

بيانات الدورية: Publisher: Elsevier Country of Publication: Netherlands NLM ID: 101534770 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-4076 (Electronic) Linking ISSN: 18794068 NLM ISO Abbreviation: J Geriatr Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Brain Neoplasms*/therapy , Neoplasms*/epidemiology, Aged ; Humans ; Cross-Sectional Studies ; Geriatric Assessment ; Karnofsky Performance Status ; Polypharmacy ; Middle Aged ; Observational Studies as Topic

المؤلفون: Bytnar JA; Murtha Cancer Center Research Program, Department of Surgery, Uniformed Services University of the Health Sciences, Bethesda, MD, USA.; The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc, Bethesda, MD, USA., Lin J; Murtha Cancer Center Research Program, Department of Surgery, Uniformed Services University of the Health Sciences, Bethesda, MD, USA.; The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc, Bethesda, MD, USA.; Department of Preventive Medicine and Biostatistics, Uniformed Services University of the Health Sciences, Bethesda, MD, USA., Theeler BJ; Department of Neurology, Uniformed Services University of the Health Sciences, Bethesda, MD, USA., Scher AI; Department of Preventive Medicine and Biostatistics, Uniformed Services University of the Health Sciences, Bethesda, MD, USA., Shriver CD; Murtha Cancer Center Research Program, Department of Surgery, Uniformed Services University of the Health Sciences, Bethesda, MD, USA., Zhu K; Murtha Cancer Center Research Program, Department of Surgery, Uniformed Services University of the Health Sciences, Bethesda, MD, USA. kangmin.zhu@usuhs.edu.; The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc, Bethesda, MD, USA. kangmin.zhu@usuhs.edu.; Department of Preventive Medicine and Biostatistics, Uniformed Services University of the Health Sciences, Bethesda, MD, USA. kangmin.zhu@usuhs.edu.

المصدر: Cancer causes & control : CCC [Cancer Causes Control] 2022 Sep; Vol. 33 (9), pp. 1135-1144. Date of Electronic Publication: 2022 Jul 15.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Kluwer Academic Publishers Country of Publication: Netherlands NLM ID: 9100846 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-7225 (Electronic) Linking ISSN: 09575243 NLM ISO Abbreviation: Cancer Causes Control Subsets: MEDLINE

مواضيع طبية MeSH: Brain Neoplasms*/diagnosis , Brain Neoplasms*/epidemiology , Mental Disorders*/diagnosis , Mental Disorders*/epidemiology , Mental Disorders*/psychology , Military Health Services* , Military Personnel*, Case-Control Studies ; Humans ; Odds Ratio

المؤلفون: Jammula V; Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA., Rogers JL; Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA., Vera E; Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA., Christ A; Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA., Leeper HE; Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA., Acquaye A; Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA., Briceno N; Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA., Choi A; Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA., Grajkowska E; Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA., Levine JE; Office of Information Technology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA., Lindsley M; Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA., Reyes J; Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA., Roche KN; Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA., Timmer M; Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA., Boris L; Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA., Burton E; Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA., Lollo N; Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA., Panzer M; Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA., Smith-Cohn MA; Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA., Penas-Prado M; Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA., Pillai V; Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA., Theeler BJ; Department of Neurology, Uniformed Services University of the Health Sciences, Bethesda, Maryland, USA., Wu J; Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA., Gilbert MR; Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA., Armstrong TS; Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.

المصدر: Neuro-oncology practice [Neurooncol Pract] 2022 May 14; Vol. 9 (5), pp. 429-440. Date of Electronic Publication: 2022 May 14 (Print Publication: 2022).

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Oxford University Press Country of Publication: England NLM ID: 101640528 Publication Model: eCollection Cited Medium: Print ISSN: 2054-2577 (Print) Linking ISSN: 20542577 NLM ISO Abbreviation: Neurooncol Pract Subsets: PubMed not MEDLINE

المؤلفون: Goodell JC; Clinical Pharmacology Program, Office of the Clinical Director, National Cancer Institute, Bethesda, MD, USA., Zimmerman SM; Clinical Pharmacology Program, Office of the Clinical Director, National Cancer Institute, Bethesda, MD, USA., Peer CJ; Clinical Pharmacology Program, Office of the Clinical Director, National Cancer Institute, Bethesda, MD, USA., Prabhu V; Chimerix, Inc, Durham, NC, USA., Yin T; Clinical Pharmacology Program, Office of the Clinical Director, National Cancer Institute, Bethesda, MD, USA., Richardson WJ; Clinical Pharmacology Program, Office of the Clinical Director, National Cancer Institute, Bethesda, MD, USA., Azinfar A; Clinical Pharmacology Program, Office of the Clinical Director, National Cancer Institute, Bethesda, MD, USA., Dunn JA; Chimerix, Inc, Durham, NC, USA., Mullin M; Chimerix, Inc, Durham, NC, USA., Theeler BJ; Department of Neurology, Uniformed Services University of the Health Sciences, USA., Gilbert M; Neuro-Oncology Branch, Center for Cancer Research, National Cancer Institute, USA., Figg WD; Clinical Pharmacology Program, Office of the Clinical Director, National Cancer Institute, Bethesda, MD, USA. Electronic address: figgw@mail.nih.gov.

المصدر: Journal of pharmaceutical and biomedical analysis [J Pharm Biomed Anal] 2022 May 10; Vol. 213, pp. 114685. Date of Electronic Publication: 2022 Feb 22.

نوع المنشور: Clinical Trial; Journal Article

بيانات الدورية: Publisher: Elsevier Science Country of Publication: England NLM ID: 8309336 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-264X (Electronic) Linking ISSN: 07317085 NLM ISO Abbreviation: J Pharm Biomed Anal Subsets: MEDLINE

مواضيع طبية MeSH: Antineoplastic Agents* , Tandem Mass Spectrometry*/methods, Chromatography, High Pressure Liquid/methods ; Chromatography, Liquid ; Humans ; Reproducibility of Results